How amino acids intercalate in CaFe layered double hydroxides: A combined RIXS and NEXAFS study.

Two-dimensional layered double hydroxides (LDHs) are ideal candidates for a large number of (bio)catalytic applications due to their flexible composition and easy to tailor properties. Functionality can be achieved by intercalation of amino acids (as the basic units of peptides and proteins). To gain insight on the functionality, we apply resonant inelastic soft x-ray scattering and near edge x-ray absorption fine structure spectroscopy to CaFe LDH in its pristine form as well as intercalated with the amino acids proline and cysteine to probe the electronic structure and its changes upon intercalation.

[Perioperative Targeted Therapy for Operable, Early Stage NSCLC].

Non-small cell lung cancer (NSCLC) is characterized by high recurrence rates in the early stages. In a German cohort, recurrence-free survival after 5 years was 62% (stage IA1), 40.7% (stage IIA) and 28% (stage IIIA).

A high throughput cell stretch device for investigating mechanobiology .

Mechanobiology is a rapidly advancing field, with growing evidence that mechanical signaling plays key roles in health and disease. To accelerate mechanobiology-based drug discovery, novel systems are needed that enable mechanical perturbation of cells in a format amenable to high throughput screening. Here, both a mechanical stretch device and 192-well silicone flexible linear stretch plate were designed and fabricated to meet high throughput technology needs for cell stretch-based applications.

Nonhealing Surgical Wounds in a Patient with Plasminogen Deficiency Type 1 Successfully Treated with Intravenous Plasminogen: A Case Report.

Intravenous plasminogen replacement therapy for patients with plasminogen deficiency type 1 (hypoplasminogenemia) was recently approved for marketing in the US. In this case report, the authors describe a 33-year-old man with hypoplasminogenemia who developed nonhealing postsurgical wounds following trauma to his right hand despite receiving standard treatment for 4 months. The patient was enrolled in a compassionate-use protocol with intravenous plasminogen replacement therapy and experienced prompt resolution of surgical wounds.